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Patients with disseminated disease
<70y. 0., PS O･l
Leukapheresis, Selection of monocytes
GM/CSF 皮 IL-4 1000 IU/mL
DayO
Laparotomy, TOR 25 Gy, Bypass operation
Autologous DC I ･5x 1 07 intra-,peri･ttlmOr injection
CIosure of woundwithout drainage
Day10
Gemcitabine 1 000 mg/m2
Ro卓 u ltS
1-5 x 107 DCs were successfully induced
Treatment was feasible with fever <38 degree on Day 2-3.
Early use of gemcitabine was tolerable.

Patientsprofileandsurvivalp.0.冒:::Q:0,A. 
No chemotherapy ror6nonths T ??vR?ex ?4?ipiDays 儖utcome 鳴??R?ﾆ???5?
I 鼎R? 綿??● 姪?b?ead ?
2 田?IF ?ﾂ?鼎??○■d 亦?
3 田b? ???涛B?ead ?
4 鼎r?M ?? 鼎"?ead ?
5 鉄B?M ?ﾂ???モ?ead ?
6 鉄?.M 箸ｲ??(x｢?De.a 覆?
V○rrTlrtS 
7 鼎?iM…● ?●223 僖ead 
8 鉄?ド ?ﾂ?都R?ead 白?
9 鼎?M ????コ?DeadZ 
10 田B? ??? 貿ﾄ??ead ?
GEM Dayl ???l 田?ド 亦ｲ?白???●■d ?Qqe如 
12 田?F i 粉ｲ?姪3湯?●tdl ?roJrt■毛kn 
13 鉄B? ?ﾃｲ?｡ 姪s?Dead ?
14 田b? ?ﾂ? 涛R?eadl ?
15 田?M… 銚?( ?#?i AIhreZ 綿??B苒?
16 田$ﾒ?R? ?#r?live ?
17 ?Χﾘ???凵??C"? DeBdE , ?










:㌫:::謡giicaa,',mon'torhg before and after
DTH against recaH antigerl
MLR, JL1 2 productlon, phagocyto8is
aFL-ts.i:tg:SuStlu･.nC.T,L a"ay･ m'rn-ckhg of
Comblnatlon wfth SeCOnd the chemotherapy
Pacritaxel, CPT-1 1 etc.
MechnISmS Of escaping from Immune
SyStom
Fas/FasL, VEGF, MHC class ‖oss
Search for tho tumor relatqd antlgert8
SEREX
lmmunlty agahst tumor anglogeneSls
VEGF, VEGFR2
5trongor DC
TAT proten, lL12 gene, CD40L gene
Thl polarized DC
GNP, GTP grade ceTI processIng
書;":.p'..･,A:
Conclusion tJ/:節
･ lntratumor DC injection after 10R and bypass operation is feasible.
･ Postoperative chemotherapy can be combined with favorable
prog nosis.
･ [n selected patjents, shrinkage (or long-Stable disease) of the Liver
metastasis and decrease of tumor marker was obtained resulting ln
the longer survival.
･ Further investigations to clarify the obstacles win gIVe a better

























p GM-CSF, IL-4, TNF-a, IL-1 8
■ GENTAUR
I IFNα Pntron A)
■ Schedng-Plough
d IFN γ qmmunomax)
l Shionogl





Pt 傀弌?y?ﾅ?初回手術と術後療法 ?ｩu韜?ﾂ?蒲^時 ?ｩu靜2?]帰 ?
と遠隔転移 辻?ﾄ発形式 ?9????ｩu陝?B?ｭ熱 ?ﾘ??8｢?靜2?
1 夫Vﾆﾂ蕚?DP.lOFLadjuvant& 犯???ﾇ好 ?ゅR?29日 
rescueGEM ?回 認??2?ｶ存中 
2 富?K??PD.lOR,adjuvant& ?W&優?V??｠水浮腫 ?r絣?0日 
rescueGEM 壇ﾆ???回 認??死亡 
3 磐?粐?iverMCT.DC,rescue 班V誡?悪液賞 ?r??3日 
M1(HEP) 杯Tﾒ?iver.Skin ???ay1 倩?2?
4 磐?篳??-J.G-J.rescueGEM 邑h?"?_管炎 ?ゅ?37日 
M1(HE戸) 弾E????Day1 倩?2?
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